These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Lipid vesicles affect the aggregation of 4-hydroxy-2-nonenal-modified α-synuclein oligomers. Sardar Sinha M; Villamil Giraldo AM; Öllinger K; Hallbeck M; Civitelli L Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3060-3068. PubMed ID: 29960040 [TBL] [Abstract][Full Text] [Related]
5. Lipid peroxidation product 4-hydroxy-2-nonenal promotes seeding-capable oligomer formation and cell-to-cell transfer of α-synuclein. Bae EJ; Ho DH; Park E; Jung JW; Cho K; Hong JH; Lee HJ; Kim KP; Lee SJ Antioxid Redox Signal; 2013 Mar; 18(7):770-83. PubMed ID: 22867050 [TBL] [Abstract][Full Text] [Related]
6. Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein. Subramaniam SR; Vergnes L; Franich NR; Reue K; Chesselet MF Neurobiol Dis; 2014 Oct; 70():204-13. PubMed ID: 25016198 [TBL] [Abstract][Full Text] [Related]
7. Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson's disease? Matsumoto J; Stewart T; Sheng L; Li N; Bullock K; Song N; Shi M; Banks WA; Zhang J Acta Neuropathol Commun; 2017 Sep; 5(1):71. PubMed ID: 28903781 [TBL] [Abstract][Full Text] [Related]
8. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease. Cao Z; Wu Y; Liu G; Jiang Y; Wang X; Wang Z; Feng T Neurosci Lett; 2019 Mar; 696():114-120. PubMed ID: 30579996 [TBL] [Abstract][Full Text] [Related]
9. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein. Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536 [TBL] [Abstract][Full Text] [Related]
10. Propagation of Parkinson's disease by extracellular vesicle production and secretion. Shippey LE; Campbell SG; Hill AF; Smith DP Biochem Soc Trans; 2022 Oct; 50(5):1303-1314. PubMed ID: 36111783 [TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder? Olanow CW; Brundin P Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095 [TBL] [Abstract][Full Text] [Related]
12. Oxidative stress in vagal neurons promotes parkinsonian pathology and intercellular α-synuclein transfer. Musgrove RE; Helwig M; Bae EJ; Aboutalebi H; Lee SJ; Ulusoy A; Di Monte DA J Clin Invest; 2019 Jun; 129(9):3738-3753. PubMed ID: 31194700 [TBL] [Abstract][Full Text] [Related]
14. Secretion and Uptake of α-Synuclein Via Extracellular Vesicles in Cultured Cells. Gustafsson G; Lööv C; Persson E; Lázaro DF; Takeda S; Bergström J; Erlandsson A; Sehlin D; Balaj L; György B; Hallbeck M; Outeiro TF; Breakefield XO; Hyman BT; Ingelsson M Cell Mol Neurobiol; 2018 Nov; 38(8):1539-1550. PubMed ID: 30288631 [TBL] [Abstract][Full Text] [Related]
15. Endogenous Alpha-Synuclein is Essential for the Transfer of Pathology by Exosome-Enriched Extracellular Vesicles, Following Inoculation with Preformed Fibrils in vivo. Melachroinou K; Divolis G; Tsafaras G; Karampetsou M; Fortis S; Stratoulias Y; Papadopoulou G; Kriebardis AG; Samiotaki M; Vekrellis K Aging Dis; 2024 Apr; 15(2):869-892. PubMed ID: 37548944 [TBL] [Abstract][Full Text] [Related]
16. α-Synuclein-carrying extracellular vesicles in Parkinson's disease: deadly transmitters. Chistiakov DA; Chistiakov AA Acta Neurol Belg; 2017 Mar; 117(1):43-51. PubMed ID: 27473175 [TBL] [Abstract][Full Text] [Related]
17. Potential of extracellular vesicles in the Parkinson's disease - Pathological mediators and biomarkers. Zhao Y; Yang G Neurochem Int; 2021 Mar; 144():104974. PubMed ID: 33485881 [TBL] [Abstract][Full Text] [Related]